Parinaz Aliahmad

Dr. Parinaz (Paris) Aliahmad is Head of Research at Replicate Bioscience. She has expertise in drug development, including both small molecules therapeutics and vaccines (inclusive of nucleic acid, protein, and viral vector-based platforms) and comprehensive knowledge of the immune system as it relates to establishing host immunity with vaccines and immunotherapies, as well dampening inflammation in autoimmune disease.

Prior to Replicate Bioscience, Dr. Aliahmad was at Arena Pharmaceuticals heading development of their early-stage pipeline. She has also held positions at both Janssen and Synthetic Genomics, leading translational studies of a self-replicating RNA platform asset for infectious disease and oncology vaccines.

Dr. Aliahmad is an inventor on multiple patents for applications of synthetic biology and use of novel technologies for vaccines and therapeutics. She received a Ph.D. in Immunology from The Scripps Research Institute. Prior to this, she earned a M.S. in Immunology from the University of Toronto and a B.S. in Microbiology & Immunology from McGill University.